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Abstract A series of novel 5-substituted 2-[2-(pyri-
dyl)ethenyl]-1,3,4-oxadiazoles were efficiently synthesized
by cyclocondensation of the appropriate 3-(pyridyl)acrylo-
hydrazides with triethyl orthoesters in the presence of glacial
acetic acid. The products were identified by means of
spectroscopic methods and their pKA ionization constants
were determined. The influence of substituents on the
basicity of the pyridine system has been discussed.
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Introduction
1,3,4-Oxadiazoles belong to the group of five-membered
aromatic heterocycles, containing one oxygen and two
nitrogen atoms. Many of these compounds exhibit a wide
range of pharmaceutical and biological activities such as
antibacterial, antiviral, anti-inflammatory, analgesic, or
anticonvulsant [1–6]. Additionally, 1,3,4-oxadiazole
derivatives act as potential agents in the treatment of
cancer and AIDS [7–10]. They are also used extensively in
agriculture as herbicides, fungicides, or insecticides [11,
12]. These heterocyclic molecules are applied in the
production of heat-resistant polymers, blowing agents,
optical brighteners, and anti-corrosion agents [13–16].
Conjugated p-electronic arrangements based on the elec-
tron-deficient 1,3,4-oxadiazole ring feature excellent
electron-transporting properties with much higher quantum
efficiency in comparison to conventional fluorescent
emitters using silicon and its solid solutions (doped sili-
con). Therefore, they are used as monomers in the
production of fluorescent emitters for organic light-emit-
ting diodes, photovoltaic cells, scintillators, and
photosensitive materials [13–16]. However, many of the
previously investigated compounds applied in organic
electronics suffer from their poor processability and low
thermal and chemical stability. Due to these facts, the study
on designing and synthesis of new organic conjugated
materials whose physicochemical properties may be easily
modified seems to be reasonable.
Synthesis of 1,3,4-oxadiazoles has been first described
by Ainsworth in the 50s last century [17]. The most popular
methods to synthesize 1,3,4-oxadiazole scaffold involve
the use of N,N0-diacylhydrazines or N-acylhydrazones
(Scheme 1). Typically, cyclodehydration of N,N0-diacyl-
hydrazines is carried out using reagents such as PPA [18],
H2SO4 [19], SOCl2 [20, 21], POCl3 [22, 23], P2O5 [24]
(CF3SO2)2O [25], BF3OEt2 [26] or the Burgess reagent
[27]. 1,3,4-Oxadiazole derivatives may also be prepared by
oxidative cyclization of N-acylhydrazones with oxidizing
agents such as CAN [28], KMnO4 [29], FeCl3 [30], Br2
[31], PbO2 [32], chloramine T [33], HgO/I2 [34], hyper-
valent iodine reagents [35–41]. One-pot syntheses of these
compounds from acid hydrazides with carboxylic acids
[42] or orthoesters [43–45] in the presence of an acidic
catalyst have also been reported. Other synthetic routes
involve acylation and subsequent ring opening and ring
closure of starting tetrazoles [46, 47], heterocyclization of
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semicarbazide, thiosemicarbazide and selenosemicarbazide
derivatives [48–50], as well as transformation of 1,2,4-
oxadiazoles under the influence of UV radiation [51].
Recently, solid phase syntheses of arrangements based on
the 1,3,4-oxadiazole fragment have also been described in
the literature [52–56].
In continuation of our studies on the application of a,b-
unsaturated acid hydrazides in the synthesis of conjugated
2-[2-(aryl)ethenyl]-1,3,4-oxadiazole derivatives, we inves-
tigated structures possessing the pyridylethenyl moiety at
the a position [57]. Herein, we report the synthesis of three
types of 3-(pyridyl)acrylohydrazides and their reactions
with triethyl orthoesters. The presence of the acid-sensitive
pyridyl fragment is particularly important because it allows
the acid–base modification of the physical properties of the
indicated structures which may serve as potential mono-
mers for optoelectronics.
Results and discussion
Hydrazides of selected 3-(pyridyl)acrylic acids 5a–5c
were used as precursors of 1,3,4-oxadiazole derivatives.
These compounds were obtained from the appropriate
commercially available heteroaromatic aldehydes, 2-pyri-
dinecarboxaldehyde (1a), 3-pyridinecarboxaldehyde (1b),
and 4-pyridinecarboxaldehyde (1c) according to a few-step
procedure (Scheme 2).
In a typical synthetic procedure, the starting aldehydes
were treated with malonic acid in pyridine in the presence
of piperidine as a catalyst under Knoevenagel–Doebner
reaction conditions. Condensation and successive decar-
boxylation of intermediate dicarboxylic acids occurred
giving a,b-unsaturated monocarboxylic acids, 3-(pyri-
dyl)acrylic acids 2a–2c in high yields. The resulting acids
were neutralized with potassium hydroxide to form the
appropriate potassium salts 3a–3c which were then used in
a one-pot, two-step synthesis, yielding acid hydrazides 5a–
5c. First, the potassium salts 3a–3c were treated with ethyl
chloroformate and finally excess amounts of hydrazine
hydrate. The reaction conducted at low temperature in
acetonitrile solution resulted in the formation of the desired
hydrazides 5a–5c in satisfactory yields (73–79 %,
Scheme 2). The same hydrazides 5a–5c were also prepared
by the typical two-step transformation from the appropriate
3-(pyridyl)acrylic acids 2a–2c by esterification with
methanol and thionyl chloride followed by treatment with
hydrazine hydrate. However, the low yields of the final
hydrazides 5a–5c (35–44 %) made the above synthetic
procedure unattractive.
The resulting acid hydrazides 5a–5c were heated with an
excess of triethyl orthoesters (R = Me, Et, Ph; Scheme 3)
Scheme 1
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in glacial acetic acid, yielding a series of 2-[2-(pyri-
dyl)ethenyl]-1,3,4-oxadiazoles 6a–6i substituted at the
5-position with a phenyl or an alkyl group that have not
previously been reported in the literature. The commer-
cially available triethyl orthoesters play the dual role of the
synthon introducing the methylene carbon atom and high-
boiling solvent.
Generally, the reaction yields increased with the
increasing bulk of substituent R on the orthoester. The best
results were obtained in the case of derivatives with a
phenyl group at the 5-position (R = Ph 88–94 %, Table 1),
due to the presence of an extended conjugated system and a
higher boiling point of triethyl orthobenzoate (b.p. 240 C)
in contrast to the boiling points of the rest of the orthoesters
(b.p. 142–152 C). The rest of 1,3,4-oxadiazoles with
electron-donating alkyl groups were prepared in lower
yields. We have also observed an influence of the position
of the pyridine nitrogen atom on the reaction yields. The
highest values were obtained in the reactions conducted
with 3-(2-pyridyl)acrylohydrazide (5a, 74–92 %) and 3-(4-
pyridyl)acrylohydrazide (5c, 76–94 %, Table 1).
Our previous studies on the reactions of 3-(2-
furyl)acrylohydrazide or 3-(2-thienyl)acrylohydrazide with
triethyl orthoesters [45, 57] have shown that the reaction
times were relatively shorter (1.5–4 h), what testifies to the
higher reactivity of hydrazide reagents containing a furan
or thiophene ring in comparison to their pyridine-contain-
ing counterparts.
The structures of new products were confirmed with
elemental analysis and spectroscopic methods (1H and 13C
NMR, MS, UV, IR). In the series of 2-[2-(pyridyl)ethenyl]-
1,3,4-oxadiazoles 6a–6i, the diagnostic signals in the 1H
NMR spectra are two doublets with the coupling constants
J = 16.4 Hz associated with two protons of the ethylene
group. The value of the coupling constants suggests that
E geometric isomers of these compounds are formed in the
reaction. The proton adjacent to pyridine ring at the b
position to the 1,3,4-oxadiazole ring is seen in the range
between 7.44 and 7.72 ppm, while the proton a-
CH = appears at high fields in the range of
7.08–7.57 ppm. Interestingly, analysing the spectra of 2-[2-
(2-pyridyl)ethenyl]-1,3,4-oxadiazoles 6a–6c, one should
notice the characteristic ethylene a-CH= and b-CH= proton
shifts. These two protons are observed at a much lower
field due to the neighbouring pyridine nitrogen atom.
Furthermore, the two protons C200-H and C600-H of the
phenyl group substituted at 5-position of the 1,3,4-oxadi-
azole ring of 6c, 6f, and 6i are shifted in the 1H NMR
spectra to lower fields and appear as a doublet of doublets
Scheme 2
Scheme 3
Table 1 Products of the reaction of 3-(pyridyl)acrylohydrazides 5a–
5c with triethyl orthoesters
Product Py R Reaction time/h Yielda/% M.p./C
6a 2-Py Me 9.0 74 108–110
6b 2-Py Et 8.0 81 50–51
6c 2-Py Ph 5.0 92 126–128
6d 3-Py Me 10.0 69 116–118
6e 3-Py Et 8.5 78 54–56
6f 3-Py Ph 6.0 88 169–171
6g 4-Py Me 9.0 76 118–120
6h 4-Py Et 8.0 84 62–65
6i 4-Py Ph 4.5 94 172–174
a Yield with respect to the starting hydrazide 5a–5c
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in the range from 8.10 to 8.13 ppm. Such significant
changes in the chemical shifts could result from the prox-
imity of these atoms to the ring’s nitrogen and oxygen
atoms. In the 13C NMR spectra of 1,3,4-oxadiazoles 6a–6i,
the characteristic signals are peaks of ethylene carbon
atoms a-CH= and b-CH=, which are observed in ranges of
112–114 ppm and 133–139 ppm, respectively. The ring
carbon atom C2 is seen in the range between 163 and
166 ppm, while the location of the second carbon atom C5
depends on the type of the substituent and appears between
164 and 170 ppm.
To establish the structure of derivatives 6, X-ray ana-
lysis was also performed. The molecular structure of
5-phenyl-2-[2-(2-pyridyl)ethenyl]-1,3,4-oxadiazole (6c)
and 5-phenyl-2-[2-(3-pyridyl)ethenyl]-1,3,4-oxadiazole
(6f) with the atomic numbering scheme is shown in Fig. 1.
Each of the analysed compounds consists of three rings:
I (the pyridine ring containing atoms C8–C13), II (the
oxadiazole ring containing atoms O1–C5), and III (the
phenyl ring containing atoms C14–C19). The values of the
I/II, I/III, and II/III dihedral angles are collected in Table 2.
According to collected data, it was concluded that both
molecules adopt coplanar conformation. The near planarity
of the systems favours the formation of intramolecular
hydrogen bonds and p-electron delocalization. The C–C
bonds located between the aromatic rings (C2–C6, C6–C7,
C7–C8, and C5–C14) exhibit intermediate values due to p-
electron delocalization in the molecules. This effect is
more pronounced in the more coplanar structure 6c.
The twist along the C2–C6, C7–C8, and C5–C14 bonds
is illustrated by torsion angles and it is rather small in both
compounds (Table 2). In the studied molecules, the
remaining bond lengths and angles are normal and are in
good agreement with the geometry of similar derivatives of
1,3,4-oxadiazole [58–60]. These structures are stabilized
by two intramolecular hydrogen bonds C7–H7O1 and
C15–H15AO1 (Table 3) which give rise to the five-
membered ring systems in all cases and confirm existence
of E geometrical form of both compounds.
Considering the fact that physical properties of com-
pounds are also strongly dependent on their ability to acid–
base interactions, the pKA values of 5-substituted 2-[2-
(pyridyl)ethenyl]-1,3,4-oxadiazoles 6a–6i were determined
(Table 4). The determination of the pKA dissociation con-
stants was performed according to the spectrophotometric
method of Albert and Serjeant [61] in 50 % aqueous
methanol solution (10-5 M, room temperature) due to the
low solubility of the examined compounds in water. The
Fig. 1 The molecular structure
of a 5-phenyl-2-[2-(2-
pyridyl)ethenyl]-1,3,4-
oxadiazole (6c), b 5-phenyl-2-
[2-(3-pyridyl)ethenyl]-1,3,4-
oxadiazole (6f) showing 50 %
displacement ellipsoids
(arbitrary spheres for the H
atoms). Dashed lines indicate
intramolecular hydrogen bond
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pKA values determined in aqueous methanol solution are
lower about 0.6 pKA unit comparing with those determined
in aqueous solution which is the result of different ionic
products of these solvents. Absorption maxima of the
1,3,4-oxadiazole ions were selected as analytical wave-
lengths bearing in mind their considerable shifts relative to
the maxima of the non-protonated forms. The conducted
studies have shown that the 1,3,4-oxadiazol-2-ylethenyl
moiety at positions 2, 3, or 4 of the pyridine ring causes an
increase in acidity compared to the pKA value of the un-
substituted pyridine (7, Scheme 4) [62].
Generally, 2-[2-(pyridyl)ethenyl]-1,3,4-oxadiazoles 6a–
6i are stronger acids than the corresponding vinylpyridine
derivatives 9 (Scheme 4). This is probably the result of the
presence of the electron-withdrawing 1,3,4-oxadiazole ring
conjugated via an ethenyl linker to pyridine. This leads to
the decreasing of the electron density of the ring nitrogen
atom. Among the three series of pyridine substituted 1,3,4-
oxadiazoles, 2-[2-(3-pyridyl)ethenyl]-1,3,4-oxadiazoles
6d–6f exhibit the most acidic properties, while the rest 6a–
6c and 6g–6i show the similar acid–base activities. Ana-
logical behaviour was observed in the case of differently
substituted methylpyridine derivatives 8 (Scheme 4).
Conclusion
In conclusion, we have synthesized a series of novel
5-substituted 2-[2-(pyridyl)ethenyl]-1,3,4-oxadiazoles in
the reactions of three types of differently substituted
3-(pyridyl)acrylohydrazides with triethyl orthoesters in
glacial acetic acid. This easy and efficient method has the
advantage of providing the desired products in high yields,
which makes it a useful addition to the existing synthetic
protocols. The presence of the acid-sensitive pyridyl frag-
ment is particularly important because it allows the
electronic properties modification of the indicated struc-
tures by acid–base interactions, which makes them
especially attractive for optoelectronic applications.
Experimental
All solvents and reagents were purchased from commercial
sources and were used without additional purification.
Melting points were measured using a Stuart SMP3 melting
point apparatus. Elemental analyses were performed with a
Scheme 4Table 2 Selected geometric parameters for 5-phenyl-2-[2-(2-pyri-




C2–C6 1.430 (2) 1.443 (3)
C6–C7 1.329 (2) 1.326 (3)
C7–C8 1.463 (2) 1.459 (3)
C5–C14 1.454 (2) 1.463 (4)
Torsion angles/
N3–C2–C6–C7 -177.4 (2) 173.5 (3)
C6–C7–C8–C13 3.6 (2) -5.4 (4)
N4–C5–C14–C19 8.6 (2) -15.3 (4)
Dihedral angles/
I/II 6.6 (1) 12.1 (2)
I/III 14.7 (8) 27.5 (1)
II/III 8.6 (1) 16.0 (2)
Table 3 Intramolecular hydrogen bonds geometry for 5-phenyl-2-[2-











0.93 2.57 2.897 (2) 101.4
6f 0.93 2.57 2.903 (3) 101.3
6c C(15)–
H(15A)O(1)
0.93 2.53 2.846 (2) 100.0
6f 0.93 2.55 2.860 (3) 99.7
Table 4 pKA Ionization constants of 2-[2-(pyridyl)ethenyl]-1,3,4-
oxadiazoles 6a–6i in aqueous methanol solutions
Compound Py R kANAL/nm pKA
a
6a 2-Py Me 300.5 4.03 ± 0.19
6b 2-Py Et 301.0 4.06 ± 0.22
6c 2-Py Ph 312.0 4.10 ± 0.23
6d 3-Py Me 294.0 3.92 ± 0.08
6e 3-Py Et 294.5 3.94 ± 0.16
6f 3-Py Ph 309.5 3.72 ± 0.19
6g 4-Py Me 290.5 4.02 ± 0.15
6h 4-Py Et 291.0 4.09 ± 0.17
6i 4-Py Ph 306.0 4.21 ± 0.12
a Determined by spectrophotometric method (H2O/MeOH, 1:1 v/v); rt
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VarioEL analyser. UV spectra were recorded on a Jasco
V-650 spectrophotometer. The 1H and 13C NMR spectra
were recorded on an Agilent 400-MR spectrometer in
DMSO-d6, CDCl3, or CD3OD solutions using TMS as the
internal standard. Thin-layer chromatography was per-
formed on silica gel 60 F254 (Merck) thin-layer
chromatography plates using MeOH/CHCl3 (1:4 v/v) as the
mobile phase. FT-IR spectra were recorded between 4000
and 650 cm-1 on an FT-IR Nicolet 6700 apparatus with a
Smart iTR accessory. Mass spectra were obtained on a GC/
MS Agilent Technologies 7890A/5975C System with triple
axis detector using the EI technique (70 eV). The pKA
ionization constants of 2-[2-(pyridyl)ethenyl]-1,3,4-oxadi-
azoles 6a–6i were determined by spectrophotometric
method of Albert and Serjeant in 50 % aqueous methanol
solutions (10-5 M) at room temperature.
General procedure for the synthesis
of 3-(pyridyl)acrylic acids 2a–2c
A mixture of 32.1 g pyridinecarboxaldehyde 1a–1c
(0.30 mol) and 31.2 g malonic acid (0.30 mol) in a solu-
tion of 30 cm3 pyridine and 1 cm3 piperidine was heated in
a steam bath and stirred for 2 h. After cooling to room
temperature, the precipitate was collected by filtration,
washed with H2O and dried. The crude product was crys-
tallized from a EtOH/H2O mixture, yielding the
corresponding pure 3-(pyridyl)acrylic acid 2a–2c.
3-(2-Pyridyl)acrylic acid (2a)
White solid; yield 42.0 g (94 %); m.p.: 201–203 C (Ref.
[63] 202–204 C).
3-(3-Pyridyl)acrylic acid (2b)
White solid; yield 41.1 g (92 %); m.p.: 232–234 C (Ref.
[64] 232–235 C).
3-(4-Pyridyl)acrylic acid (2c)
White solid; yield 42.9 g (96 %); m.p.: 277–279 C (Ref.
[65] 277–280 C).
General procedure for the preparation
of 3-(pyridyl)acrylohydrazides 5a–5c
The appropriate 3-(pyridyl)acrylic acid 2a–2c (14.9 g,
0.10 mol) was slowly added to a stirred solution of 5.6 g
KOH (0.10 mol) in 100 cm3 H2O. The mixture was stirred
for approximately 10 min and then concentrated using a
rotary evaporator. The precipitate was washed with
2 9 50 cm3 Et2O, collected by filtration and air dried to give
the corresponding crude potassium salt as a white solid:
18.1 g (97 %) 3a, 17.8 g (95 %) 3b, and 18.3 g (98 %) 3c.
To a stirred suspension of 16.8 g potassium salt 3a–3c
(0.09 mol) in 100 cm3 MeCN was added a 1 % solution of
pyridine in 30 cm3 MeCN and 9.8 g ethyl chloroformate
(0.09 mol). The reaction mixture was agitated at 0 C for
2 h and then slowly poured into a stirred, ice-cooled sus-
pension of 9.0 g hydrazine hydrate (0.18 mol) in 100 cm3
MeCN. After filtration, the filtrate was kept in an ice box
overnight, then washed with 2 9 50 cm3 saturated aqueous
Na2CO3 solution, dried over MgSO4, and concentrated
using a rotatory evaporator. The crude product was purified
by column chromatography with silica gel and an eluent of
MeOH/CHCl3 (1:4 v/v) to yield the 3-(pyridyl)acrylic acid
hydrazides 5a–5c.
3-(2-Pyridyl)acrylohydrazide (5a, C8H9N3O)
Yellow solid; yield 11.0 g (75 %); m.p.: 108–110 C;
Rf = 0.31 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
DMSO-d6): d = 9.53 (1H, s, NH), 8.58 (1H, d,
J = 4.0 Hz, C60-H), 7.80 (1H, t, J = 7.6 Hz, C40-H),
7.54 (1H, d, J = 7.6 Hz, C30-H), 7.45 (1H, d, J = 15.6 Hz,
b-CH=), 7.34–7.31 (1H, m, C50-H), 7.00 (1H, d,
J = 15.6 Hz, a-CH=), 4.51 (2H, br s, NH2) ppm;
13C
NMR (100.6 MHz, DMSO-d6): d = 164.0 (CO), 153.0,
149.8, 137.6, 137.2, 124.2, 124.0, 123.9 ppm; IR (ATR):
V = 3,277, 3,176, 3,054, 3,026, 1,989, 1,659, 1,591, 1,486,
1,474, 1,437, 1,336, 1,305, 1,249, 1,218, 1,188, 1,126,
1,095, 1,048, 955, 922, 892, 872, 857, 728, 676 cm-1; UV–
Vis (MeOH): kmax (e 9 10
-3) = 291.0 (13.65), 250.0
(13.46), 201.0 (16.65) nm (mol-1 dm3 cm-1); MS (EI,
70 eV): m/z (%) = 163 (M?, 18), 148 (22), 133 (79), 132
(100), 130 (27), 105 (21), 104 (92), 79 (40), 78 (65), 77
(13), 76 (10), 52 (15), 51 (30).
3-(3-Pyridyl)acrylohydrazide (5b)
Yellow solid; yield 10.7 g (73 %); m.p.: 128–130 C (Ref.
[66] 126 C).
3-(4-Pyridyl)acrylohydrazide (5c)
Yellow solid; yield 11.6 g (79 %); m.p.: 149–151 C (Ref.
[67] 150–151 C).
General procedure for the synthesis of 5-substituted
2-[2-(pyridyl)ethenyl]-1,3,4-oxadiazoles 6a–6i
The starting 3-(pyridyl)acrylohydrazide 5a–5c (1.63 g,
10.0 mmol) was added to a mixture of the appropriate
triethyl orthoester (20.0 mmol) and 10 cm3 glacial AcOH.
The mixture was kept under reflux until the starting
hydrazide was fully consumed (monitored by TLC,
4.5–10 h). After cooling, the excessive orthoester and
AcOH were evaporated under reduced pressure. The crude
products 6a–6i were crystallized from appropriate solvents.
5-Methyl-2-[2-(2-pyridyl)ethenyl]-1,3,4-oxadiazole
(6a, C10H9N3O)
White solid; yield 1.38 g (74 %); m.p.: 108–110 C;
Rf = 0.66 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
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CD3OD): d = 8.66 (1H, d, J = 4.0 Hz, C60-H), 7.91 (1H,
t, J = 7.6 Hz, C40-H), 7.71 (1H, d, J = 7.6 Hz, C30-H),
7.66 (1H, d, J = 16.4 Hz, b-CH=), 7.55 (1H, d,
J = 16.4 Hz, a-CH=), 7.45–7.42 (1H, m, C50-H), 2.65
(3H, s, CH3) ppm;
13C NMR (100.6 MHz, CD3OD):
d = 165.8, 165.7, 154.1, 150.9, 138.9, 138.8, 125.6, 125.2,
114.5, 10.7 (CH3) ppm; IR (ATR): V = 3,038, 2,162,
1,648, 1,577, 1,529, 1,476, 1,437, 1,390, 1,353, 1,324,
1,230, 1,162, 1,100, 1,041, 991, 986, 904, 792, 675,
665 cm-1; UV–Vis (MeOH): kmax (e 9 10
-3) = 302.0
(21.17), 263.5 (14.13), 201.5 (9.96) nm (mol-1 dm3 cm-1);
MS (EI, 70 eV): m/z (%) = 187 (M?, 40), 186 (100), 144




White solid; yield 1.63 g (81 %); m.p.: 50–51 C;
Rf = 0.68 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CD3OD): d = 8.66 (1H, d, J = 4.0 Hz, C60-H), 7.91 (1H,
t, J = 7.6 Hz, C40-H), 7.71 (1H, d, J = 7.6 Hz, C30-H),
7.66 (1H, d, J = 16.4 Hz, b-CH=), 7.56 (1H, d,
J = 16.4 Hz, a-CH=), 7.45–7.42 (1H, m, C50-H), 3.01
(2H, q, J = 7.6 Hz, CH2), 1.46 (3H, t, J = 7.6 Hz, CH3)
ppm; 13C NMR (100.6 MHz, CD3OD): d = 169.7, 165.5,
154.1, 150.9, 138.9, 138.8, 125.6, 125.2, 114.5, 19.8 (CH2),
10.8 (CH3) ppm; IR (ATR): V = 3,188, 3,062, 1,674,
1,596, 1,554, 1,502, 1,471, 1,420, 1,355, 1,322, 1,288,
1,230, 1,178, 1,134, 1,099, 1,070, 1,037, 967, 919, 891,
841, 829, 673, 662 cm-1; UV–Vis (MeOH): kmax
(e 9 10-3) = 302.5 (17.44), 264.5 (11.03), 200.5 (7.53)
nm (mol-1 dm3 cm-1); MS (EI, 70 eV): m/z (%) = 201
(M?, 46), 200 (13), 144 (32), 132 (22), 117 (28), 116 (100),
104 (13), 90 (10), 89 (14), 78 (21), 57 (17).
5-Phenyl-2-[2-(2-pyridyl)ethenyl]-1,3,4-oxadiazole
(6c, C15H11N3O)
White solid; yield 2.29 g (92 %); m.p.: 126–128 C;
Rf = 0.70 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CD3OD): d = 8.61 (1H, d, J = 4.0 Hz, C60-H), 8.10 (2H,
dd, J = 8.0, 1.6 Hz, C200-H, C600-H), 7.86 (1H, t,
J = 7.6 Hz, C40-H), 7.72 (1H, d, J = 16.4 Hz, b-CH=),
7.67 (1H, d, J = 7.6 Hz, C30-H), 7.61-7.58 (3H, m, C300-H,
C400-H, C500-H), 7.57 (1H, d, J = 16.4 Hz, a-CH=),
7.39–7.36 (1H, m, C50-H) ppm; 13C NMR (100.6 MHz,
CD3OD): d = 165.7, 165.3, 153.9, 150.8, 139.2, 138.6,
133.3, 130.3, 127.9, 125.5, 125.2, 124.4, 114.3 ppm; IR
(ATR): V = 2,919, 2,850, 1,969, 1,667, 1,585, 1,567,
1,519, 1,473, 1,450, 1,430, 1,373, 1,315, 1,275, 1,221,
1,190, 1,152, 1,093, 1,071, 1,015, 993, 973, 845, 830, 744,
690 cm-1; UV–Vis (MeOH): kmax (e 9 10
-3) = 312.0
(17.73), 245.5 (8.18), 201.5 (16.65) nm
(mol-1 dm3 cm-1); MS (EI, 70 eV): m/z (%) = 249
(M?, 55), 193 (14), 192 (17), 144 (50), 132 (26), 116




White solid; yield 1.29 g (69 %); m.p.: 116–118 C;
Rf = 0.53 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CDCl3): d = 8.76 (1H, d, J = 2.0 Hz, C20-H), 8.61 (1H,
dd, J = 4.8, 1.6 Hz, C60-H), 7.89 (1H, dt, J = 8.0, 2.0 Hz,
C40-H), 7.50 (1H, d, J = 16.4 Hz, b-CH=), 7.37 (1H, dd,
J = 8.0, 4.8 Hz, C50-H), 7.08 (1H, d, J = 16.4 Hz, a-
CH=), 2.60 (3H, s, CH3) ppm;
13C NMR (100.6 MHz,
CDCl3): d = 163.9, 163.4, 150.6, 149.2, 134.7, 133.4,
130.5, 123.8, 112.1, 11.0 (CH3) ppm; IR (ATR):
V = 3,050, 3,019, 2,164, 1,645, 1,575, 1,524, 1,503,
1,484, 1,446, 1,419, 1,362, 1,236, 1,131, 1,051, 1,024,
967, 954, 859, 819, 800, 747, 717, 674, 664 cm-1; UV–Vis
(MeOH): kmax (e 9 10
-3) = 293.5 (21.38), 283.5 (21.64),
200.5 (10.05) nm (mol-1 dm3 cm-1); MS (EI, 70 eV): m/
z (%) = 187 (M?, 34), 186 (100), 144 (10), 132 (12), 116
(28), 104 (11), 90 (12), 51 (10), 43 (22).
5-Ethyl-2-[2-(3-pyridyl)ethenyl]-1,3,4-oxadiazole
(6e, C11H11N3O)
White solid; yield 1.57 g (78 %); m.p.: 54–56 C;
Rf = 0.61 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CDCl3): d = 8.77 (1H, d, J = 2.0 Hz, C20-H), 8.61 (1H,
dd, J = 4.8, 1.6 Hz, C60-H), 7.90 (1H, dt, J = 8.0, 2.0 Hz,
C40-H), 7.50 (1H, d, J = 16.4 Hz, b-CH=), 7.38 (1H, dd,
J = 8.0, 4.8 Hz, C50-H), 7.10 (1H, d, J = 16.4 Hz, a-
CH=), 2.94 (2H, q, J = 7.6 Hz, CH2), 1.44 (3H, t,
J = 7.6 Hz, CH3) ppm;
13C NMR (100.6 MHz, CDCl3):
d = 167.5, 163.7, 150.6, 149.3, 134.6, 133.3, 130.6, 123.8,
112.2, 19.1 (CH2), 10.7 (CH3) ppm; IR (ATR): V = 3,178,
3,073, 1,645, 1,570, 1,504, 1,463, 1,450, 1,412, 1,379,
1,344, 1,315, 1,248, 1,193, 1,129, 1,083, 1,024, 955, 860,
806, 792, 699, 675 cm-1; UV–Vis (MeOH): kmax
(e 9 10-3) = 294.5 (22.24), 284.0 (22.31), 201.0 (11.39)
nm (mol-1 dm3 cm-1); MS (EI, 70 eV): m/z (%) = (M?,
32), 200 (100), 144 (10), 132 (12), 116 (28), 104 (11), 57
(14).
5-Phenyl-2-[2-(3-pyridyl)ethenyl]-1,3,4-oxadiazole (6f)




White solid; yield 1.42 g (76 %); m.p.: 118–120 C;
Rf = 0.55 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CDCl3): d = 8.67 (2H, d, J = 6.0 Hz, C20-H, C60-H), 7.44
(1H, d, J = 16.4 Hz, b-CH=), 7.40 (2H, d, J = 6.0 Hz,
C30-H, C50-H), 7.20 (1H, d, J = 16.4 Hz, a-CH=), 2.61
(3H, s, CH3) ppm;
13C NMR (100.6 MHz, CDCl3):
d = 163.7, 163.6, 150.5, 141.8, 135.6, 121.2, 114.3, 11.0
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(CH3) ppm; IR (ATR): V = 3,188, 3,061, 2,168, 1,946,
1,674, 1,646, 1,577, 1,557, 1,507, 1,471, 1,439, 1,402,
1,360, 1,323, 1,287, 1,233, 1,220, 1,196, 1,134, 1,097,
1,049, 962, 914, 890, 880, 746, 729, 709, 674, 663 cm-1;
UV–Vis (MeOH): kmax (e 9 10
-3) = 291.0 (23.16), 282.0
(24.45), 209.5 (9.42) nm (mol-1 dm3 cm-1); MS (EI,
70 eV): m/z (%) = 187 (M?, 66), 186 (100), 132 (17), 130
(12), 117 (10), 104 (11), 90 (16), 89 (10), 78 (11), 51 (13).
5-Ethyl-2-[2-(4-pyridyl)ethenyl]-1,3,4-oxadiazole
(6h, C11H11N3O)
White solid; yield 1.69 g (84 %); m.p.: 62–65 C;
Rf = 0.59 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CDCl3): d = 8.68 (2H, d, J = 6.0 Hz, C20-H, C60-H), 7.44
(1H, d, J = 16.4 Hz, b-CH=), 7.40 (2H, d, J = 6.0 Hz,
C30-H, C50-H), 7.22 (1H, d, J = 16.4 Hz, a-CH=), 2.95
(2H, q, J = 7.6 Hz, CH2), 1.44 (3H, t, J = 7.6 Hz, CH3)
ppm; 13C NMR (100.6 MHz, CDCl3): d = 167.3, 163.9,
150.5, 141.7, 135.6, 121.2, 114.3, 19.2 (CH2), 10.8 (CH3)
ppm; IR (ATR): V = 3,194, 3,082, 1,646, 1,587, 1,549,
1,502, 1,484, 1,411, 1,335, 1,291, 1,227, 1,170, 1,124,
1,092, 1,060, 1,037, 967, 925, 871, 821, 677, 662 cm-1;
UV–Vis (MeOH): kmax (e 9 10
-3) = 292.0 (24.28), 282.5
(25.75), 210.0 (10.18) nm (mol-1 dm3 cm-1); MS (EI,
70 eV): m/z (%) = 201 (M?, 52), 200 (100), 132 (16), 116
(23), 104 (11), 90 (14), 89 (10), 78 (21), 57 (17).
5-Phenyl-2-[2-(4-pyridyl)ethenyl]-1,3,4-oxadiazole
(6i, C15H11N3O)
White solid; yield 2.34 g (94 %); m.p.: 172–174 C;
Rf = 0.67 (MeOH/CHCl3, 1:4 v/v);
1H NMR (400 MHz,
CDCl3): d = 8.69 (2H, d, J = 6.0 Hz, C20-H, C60-H), 8.13
(2H, dd, J = 8.0, 1.6 Hz, C200-H, C600-H), 7.56 (1H, d,
J = 16.4 Hz, b-CH=), 7.55–7.51 (3H, m, C300-H, C400-H,
C500-H), 7.43 (2H, d, J = 6.0 Hz, C30-H, C50-H), 7.29 (1H,
d, J = 16.4 Hz, a-CH=) ppm; 13C NMR (100.6 MHz,
CDCl3): d = 164.5, 163.3, 150.6, 141.8, 135.9, 132.0,
129.1, 127.0, 123.4, 121.2, 114.3 ppm; IR (ATR):
V = 3,188, 3,062, 1,962, 1,674, 1,596, 1,555, 1,502,
1,471, 1,420, 1,356, 1,322, 1,288, 1,230, 1,178, 1,134,
1,099, 1,070, 1,038, 971, 918, 891, 880, 817, 728,
663 cm-1; UV–Vis (MeOH): kmax (e 9 10
-3) = 307.0
(29.03), 248.0 (13.56), 202.0 (26.35) nm
(mol-1 dm3 cm-1); MS (EI, 70 eV): m/z (%) = 249
(M?, 57), 248 (100), 132 (14), 105 (47), 78 (10), 77
(43), 51 (13).
X-ray crystal structure analysis for 6c and 6f
The single crystal of 5-phenyl-2-[2-(2-pyridyl)ethenyl]-
1,3,4-oxadiazole (6c) and 5-phenyl-2-[2-(3-pyridyl)eth-
enyl]-1,3,4-oxadiazole (6f) were used for data collection at
100.0(1) K on a four-circle Oxford Diffraction Xcalibur
diffractometer equipped with a two-dimensional area CCD
detector using graphite-monochromatized MoKa radiation
(k = 0.71073 A˚) and the x-scan technique. Integration of
the intensities and correction for Lorenz and polarization
effects were performed using CrysAlis RED software [69].
The crystal structures were solved by direct methods and
refined by a full-matrix least-squares method on F2 using
the program SHELXL-97 [70].
Complete crystallographic details for 6c and 6f are
available as Supplementary data (CCDC 994,076 and
994,077) and have been deposited at the Cambridge
Crystallographic Data Centre (CCDC), 12 Union Road,
Cambridge, CB21EZ, UK; e-mail: depos-
it@ccdc.cam.ac.uk or http://www.ccdc.cam.ac.uk. Any
request to the CCDC for this material should quote the full
literature citation.
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